A study in humans demonstrated that the mir-196a was not significantly regulated with age in peripheral blood from physiologically unaffected individuals, serving as a negative control [Meder et al. DOI:10.1373/clinchem.2014.224238]. In human skin burn pathology, the mir-196a was downregulated in burn hypertrophic scar and its derived fibroblasts compared to normal fibroblasts and was also downregulated in heat-shocked fibroblasts four hours post-burn [Siu et al. DOI:10.1111/wrr.13100]. In doping control research, the mir-196a was identified as a potential microRNA marker for stored red blood cells in the context of autologous blood transfusion, as its expression changed upon storage of red blood cells at 4°C [Reichel DOI:10.1016/J.Forsciint.2011.07.031].